Orthobiologics products are widely used during orthopedic surgery that facilitates quick healing. Various biological substances are used in Orthobiologics that help musculoskeletal injuries to heal faster. Orthobiologics play and important role in healing of tendon, ligament, bone formation cartilage regeneration and other orthopedic related injuries. Researchers are now focusing on stem cells and regenerative medicine to cure arthritis and orthopedic related disorders. Market Industry Reports (MIR) has published a new report titled "Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global orthobiologics market was valued at over US$ 5.5 Bn. in 2017. It is anticipated to grow at a CAGR of 5.2% from 2019 to 2030.
The growth of this market can be attributed to the factors such as, increase in sports injuries and road accidents, awareness among patients & athletes, rise in obesity rate, and continuously aging population. According to the World Health Organization, 2017, fatal road accidents are the second primary cause of factures and accidental injury worldwide with almost 646000 individuals die every year around the world.
Major Key Players of the Orthobiologics Market are:
Medtronic, DePuy Synthes, Zimmer Biomet, MTF, Sanofi, Bioventus, Arthrex, Seikagaku and NuVasive among others.
Read More @ http://www.sbwire.com/press-releases/orthobiologics-market-to-witness-growth-acceleration-during-2019-2030-medtronic-depuy-synthes-zimmer-biomet-1278370.htm
Major Types of Orthobiologics Market covered are:
Viscosupplementation
Allograft
Stem Cell Therapy
Demineralized Bone Matrix (DBM)
Major Applications of Orthobiologics Market covered are:
Spinal Fusion
Reconstructive Surgery
Soft Tissue
The growth of this market can be attributed to the factors such as, increase in sports injuries and road accidents, awareness among patients & athletes, rise in obesity rate, and continuously aging population. According to the World Health Organization, 2017, fatal road accidents are the second primary cause of factures and accidental injury worldwide with almost 646000 individuals die every year around the world.
Major Key Players of the Orthobiologics Market are:
Medtronic, DePuy Synthes, Zimmer Biomet, MTF, Sanofi, Bioventus, Arthrex, Seikagaku and NuVasive among others.
Read More @ http://www.sbwire.com/press-releases/orthobiologics-market-to-witness-growth-acceleration-during-2019-2030-medtronic-depuy-synthes-zimmer-biomet-1278370.htm
Collaborations and rising R&D investments by the prominent biotechnology and medical device companies are leading to the introduction of advanced orthobiologics which is expected to widen the base for growth of the orthobiologics. For instance, Bone Biologics Corp., is in development stages of its orthobiological product bone growth stimulator Nell-1, in collaboration (2015) with the University of California. This subsequent increase in R&D efforts led to development of a series of pipeline products that is projected to provide the vertical with profitable growth opportunities in the future.
Major Types of Orthobiologics Market covered are:
Viscosupplementation
Allograft
Stem Cell Therapy
Demineralized Bone Matrix (DBM)
Major Applications of Orthobiologics Market covered are:
Spinal Fusion
Reconstructive Surgery
Soft Tissue
No comments:
Post a Comment